Advertisement

Document › Details
BIA Separations d.o.o.. (9/17/18). "Press Release: BIA Separations Expands with New Upstream Processing Facility". Ajdovšcina.
![]() |
Organisation | BIA Separations d.o.o. |
Group | Sartorius (Group) | |
Organisation 2 | Zyme Communications Ltd. | |
![]() |
Product | chromatography |
Product 2 | biopharmaceutical | |
![]() |
Person | Štrancar, Aleš (BIA Separations 201309 CEO + Chief Business Development Officer) |
Person 2 | Krapež Trošt, Jana (BIA Separations 201801 Head of Marketing | |
> Investment in new lab will support integrated optimisation of upstream and downstream process development
> Provides single source of expertise for scaled production of complex biologics for gene therapy and vaccines
BIA Separations, a leading biochromatography development and manufacturing company, today announced the expansion of its services with the opening of a new upstream processing (USP) laboratory.
The investment in the new facility comes in response to customer demand for services that optimise the critical interface between upstream and downstream processing for the robust and scalable production of complex molecules and biologics, such as viral vectors, phages, and exosomes. The new USP facility will ensure biopharmaceutical manufacturing processing are developed and delivered to customers in an integrated way, with full coordination of critical steps, for example: upstream choice of cell line; source and supply of materials; bioreactor processing parameters and the consequential impact on downstream product purification; formulation; and stability profiles.
Aleš Štrancar, CEO of BIA Separations commented: “This month BIA Separations celebrates our 20th Anniversary and we are delighted to mark it with the opening of this new USP facility. Alongside our many years’ experience and expertise in understanding and controlling bioprocesses, we now have the capability to manage the interface between upstream and downstream processes, which is key for complex biologics production.”
ENDS
Notes to Editors
For a high resolution image please contact sarah.jeffery@zymecommunications.com
Media contact
Sarah Jeffery
Zyme Communications
E: sarah.jeffery@zymecommunications.com
T: +44 (0)7771 730 919
At BIA Separations
Jana Krapež Trošt
Head of Marketing
E: marketing@monoliths.com
T: +386 (0)59 699 505
About BIA Separations www.biaseparations.com
BIA Separations is the leading developer and manufacturer of CIM® (Convective Interaction Media) monolithic chromatographic columns for production, purification, and analytics of large biomolecules. The company has research and production facilities in Slovenia, with sales offices and distributors throughout the world.
BIA Separations mission is to develop and produce CIM® monolithic columns of highest quality and provide superior research and method development services for purification and analytics of biomolecules. In addition the company aims to provide unique in-process control tools to better understand and control the bioprocesses.
Record changed: 2023-06-05 |
Advertisement

More documents for Sartorius (Group)
- [1] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
- [2] Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen....
- [3] Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen....
- [4] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....
- [5] Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent ". Aubagne....
- [6] Sartorius AG. (7/21/22). "Press Release: Sartorius Remains on Growth Track. Figures for the First Half of 2022 – Sales Revenue up 20.9 Percent in Constant Currencies, Underlying EBITDA up 25.6 Percent, Underlying EBITDA Margin 33.9 Percent". Göttingen....
- [7] Waters Corporation. (10/27/21). "Press Release: Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development". Milford, MA & Göttingen....
- [8] Satorius AG. (1/6/21). "Press Release: Sartorius to Acquire Novasep’s Chromatography Process Equipment Division". Göttingen....
- [9] Sartorius AG. (10/2/20). "Press Release: Purification Specialist BIA Separations to Become Part of Sartorius". Göttingen....
- [10] BIA Separations d.o.o.. (7/8/20). "Press Release: BIA Separations Signs Two New Distribution Agreements Extending Coverage in Asia Pacific". Ajdovšcina....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top